FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals
Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of SIMLANDI (adalimumab-ryvk) injection. This approval positions ... Read More
Avangrid announces significant milestone for Vineyard Wind 1 project
Avangrid, Inc., a leader in sustainable energy and part of the Iberdrola Group, along with Copenhagen Infrastructure Partners (CIP) through its affiliate Vineyard Offshore, have ... Read More
Infibeam Avenues invests $10m in XDuce to boost US market presence
Infibeam Avenues Ltd, a leading AI-powered fintech company listed on the stock exchange, has made a significant investment of USD 10 million to acquire a ... Read More
Rapid spread of Norovirus in Northeastern US: Public health alert issued
The United States is grappling with a rapidly spreading outbreak of norovirus, particularly in its northeastern region. According to recent data released by the Centers ... Read More
US military engages unknown aerial object amid rising airspace intrusions
In a sensational turn of events reminiscent of last year's Chinese spy balloon saga, US jets have once again been mobilized to intercept a high-altitude ... Read More
Private US spacecraft operated by Intuitive Machines achieves historic moon landing
In a monumental achievement that has reshaped the landscape of lunar exploration, a private US spacecraft operated by Intuitive Machines has successfully landed on the ... Read More
Esperanza Capital and Andros Capital secure strategic ExxonMobil assets in Gulf of Mexico
Esperanza Capital Partners (ECP) and Andros Capital Partners LLC (Andros) have announced a definitive agreement to acquire assets in the Ursa and Princess Fields (Ursa) ... Read More
FDA approves first generic RECTIV ointment by Cosette Pharmaceuticals
In a landmark move for the pharmaceutical industry, Cosette Pharmaceuticals, Inc. has received approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated ... Read More
Chord Energy and Enerplus forge $11bn merger to create Williston Basin powerhouse
Chord Energy Corporation (NASDAQ: CHRD) and Enerplus Corporation (TSX: ERF) (NYSE: ERF) have unveiled a landmark merger agreement, valued at approximately $11 billion in stock ... Read More
Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML
Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology, has achieved a significant milestone with the ... Read More